Tomorrow Biostasis, founded in 2019 by German doctor Emil Kendziorra, is the first European company to freeze the bodies of freshly deceased individuals in the hope of being able to revive them in the future.
BERLIN – In 2019, the German doctor Emil Kendziorra founded Tomorrow Biostasis, the first European company to offer a cryopreservation program, which aims to freeze the bodies of recently deceased individuals, hoping that one day they will be able to revive them. The bodies are stored in cells filled with liquid nitrogen at a temperature of -196 degrees Celsius, where they will remain until scientific advancements allow the diseases that led to their death to be cured.
How does it work?
Bodies arrive in Switzerland once the client has passed away, and their body is prepared in the converted ambulance.
Kendziorra explains: “We immediately start cooling down the vehicle. At the same time, we perform chest compressions and administer oxygen through a breathing mask. Not to resuscitate the deceased, but to slow down the onset of cellular death and ultimately stop it completely with cooling.” “They remain exactly as they died. We cool them down and bring them to Switzerland as quickly as possible” to a location with very low crime rates and where neither floods nor earthquakes are expected.
The founder Emil Kendziorra has an ambitious goal: “Building a world where people can choose how long to live, regardless of where they are, who they are, and their financial resources.” However, the service is not affordable for everyone: whole-body cryopreservation requires an insurance coverage of 200,000 euros, while the cost drops to 60,000 euros for brain-only preservation.
The practice of cryopreservation, already widespread in the United States and China, sees its main actors in the Cryonics Institute and Alcor, both American, but now Tomorrow Biostasis is bringing this controversial technology to Europe as well. To date, there are 377 people already in cryopreservation worldwide, including 15 Italians, while approximately 5,000 are on the waiting list.
An uncertain but fascinating tomorrow
Despite the scientific uncertainty, Tomorrow Biostasis already has 400 members in its program, who pay a monthly fee of 25 euros, which will increase to 50 euros starting from June 15th. The majority of clients are men between 25 and 45 years old, coming from sectors such as consulting, sciences, medicine, IT, and engineering.
The path to immortality remains long and uncertain, but for those who believe in the reversibility of death, cryopreservation represents a bet on the future and a hope for rebirth.
Photo credits: https://it.insideover.com/scienza/e-il-terzo-giorno-lo-scongelarono-i-nuovi-orizzonti-dellibernazione.html
